Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly A Sagar

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Experimental and Clinical Psychopharmacology|March 25, 2021
No pain, all gain? Interim analyses from a longitudinal, observational study examining the impact of medical cannabis treatment on chronic pain and related symptomsStaci A Gruber, Rosemary T Smith, M Kathryn Dahlgren, et al.
Journal of Studies on Alcohol and Drugs|March 22, 2016
Marijuana Use Predicts Cognitive Performance on Tasks of Executive FunctionMary Kathryn Dahlgren, Kelly A Sagar, Megan T Racine, et al.
JAMA Psychiatry|November 4, 2020
Urinary Tetrahydrocannabinol After 4 Weeks of a Full-Spectrum, High-Cannabidiol Treatment in an Open-label Clinical TrialM Kathryn Dahlgren, Kelly A Sagar, Ashley M Lambros, et al.
Psychiatry Research. Neuroimaging|May 27, 2018
Prefrontal cortex activation during cognitive interference in nonsuicidal self-injuryM Kathryn Dahlgren, Jill M Hooley, Stephanie G Best, et al.
Mental Health and Substance Use : Dual Diagnosis|April 21, 2022
Marijuana impacts mood in bipolar disorder: a pilot studyStaci A Gruber, Kelly A Sagar, Mary K Dahlgren, et al.
Drug and Alcohol Dependence|January 19, 2020
Recreational cannabis use impairs driving performance in the absence of acute intoxicationM Kathryn Dahlgren, Kelly A Sagar, Rosemary T Smith, et al.
Frontiers in Pharmacology|October 30, 2016
Splendor in the Grass? A Pilot Study Assessing the Impact of Medical Marijuana on Executive FunctionStaci A Gruber, Kelly A Sagar, Mary K Dahlgren, et al.
Communications Medicine|November 9, 2022
Clinical and cognitive improvement following full-spectrum, high-cannabidiol treatment for anxiety: open-label data from a two-stage, phase 2 clinical trialMary Kathryn Dahlgren, Ashley M Lambros, Rosemary T Smith, et al.
Journal of the International Neuropsychological Society : JINS|July 15, 2021
An Observational, Longitudinal Study of Cognition in Medical Cannabis Patients over the Course of 12 Months of Treatment: Preliminary ResultsKelly A Sagar, M Kathryn Dahlgren, Ashley M Lambros, et al.
Plos One|June 9, 2016
Joint Effects: A Pilot Investigation of the Impact of Bipolar Disorder and Marijuana Use on Cognitive Function and MoodKelly A Sagar, M Kathryn Dahlgren, Megan T Racine, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Experimental and Clinical Psychopharmacology|March 25, 2021
No pain, all gain? Interim analyses from a longitudinal, observational study examining the impact of medical cannabis treatment on chronic pain and related symptomsStaci A Gruber, Rosemary T Smith, M Kathryn Dahlgren, et al.
Journal of Studies on Alcohol and Drugs|March 22, 2016
Marijuana Use Predicts Cognitive Performance on Tasks of Executive FunctionMary Kathryn Dahlgren, Kelly A Sagar, Megan T Racine, et al.
JAMA Psychiatry|November 4, 2020
Urinary Tetrahydrocannabinol After 4 Weeks of a Full-Spectrum, High-Cannabidiol Treatment in an Open-label Clinical TrialM Kathryn Dahlgren, Kelly A Sagar, Ashley M Lambros, et al.
Psychiatry Research. Neuroimaging|May 27, 2018
Prefrontal cortex activation during cognitive interference in nonsuicidal self-injuryM Kathryn Dahlgren, Jill M Hooley, Stephanie G Best, et al.
Mental Health and Substance Use : Dual Diagnosis|April 21, 2022
Marijuana impacts mood in bipolar disorder: a pilot studyStaci A Gruber, Kelly A Sagar, Mary K Dahlgren, et al.
Drug and Alcohol Dependence|January 19, 2020
Recreational cannabis use impairs driving performance in the absence of acute intoxicationM Kathryn Dahlgren, Kelly A Sagar, Rosemary T Smith, et al.
Frontiers in Pharmacology|October 30, 2016
Splendor in the Grass? A Pilot Study Assessing the Impact of Medical Marijuana on Executive FunctionStaci A Gruber, Kelly A Sagar, Mary K Dahlgren, et al.
Communications Medicine|November 9, 2022
Clinical and cognitive improvement following full-spectrum, high-cannabidiol treatment for anxiety: open-label data from a two-stage, phase 2 clinical trialMary Kathryn Dahlgren, Ashley M Lambros, Rosemary T Smith, et al.
Journal of the International Neuropsychological Society : JINS|July 15, 2021
An Observational, Longitudinal Study of Cognition in Medical Cannabis Patients over the Course of 12 Months of Treatment: Preliminary ResultsKelly A Sagar, M Kathryn Dahlgren, Ashley M Lambros, et al.
Plos One|June 9, 2016
Joint Effects: A Pilot Investigation of the Impact of Bipolar Disorder and Marijuana Use on Cognitive Function and MoodKelly A Sagar, M Kathryn Dahlgren, Megan T Racine, et al.
Pageof 3